Featured-images_07

BioGenCell has received the approval of both the Israeli and Belgium Ministry of Health

BioGenCell has received the approval of both the Israeli Ministry of Health (MOH) and the Belgium Ministry of Health (FAMHP-Federal Agency for Medicines and Health Products) to continue its clinical trials on a larger scale as a double-blind placebo-controlled study.

Share this Article
Font Resize